Evidence map›Paper›PMID 40404613›Full record

ArticleNature communications2025

Deep MALDI-MS spatial omics guided by quantum cascade laser mid-infrared imaging microscopy.

Lars Gruber, Stefan Schmidt, Thomas Enzlein, Huong Giang Vo, Tobias Bausbacher, James Lucas Cairns, Yasemin Ucal, Florian Keller, Martina Kerndl, Denis Abu Sammour and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lars Gruber *Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0009-0009-9955-1550
Stefan Schmidt *Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0003-2896-3290
Thomas EnzleinCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0003-1789-4090
Huong Giang VoClinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center, Mainz University, Mainz, Germany.ORCID http://orcid.org/0009-0002-2025-6313
Tobias BausbacherCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4384-5612
James Lucas CairnsCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0003-4986-1015
Yasemin UcalCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.
Florian KellerCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.
Martina KerndlInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
Denis Abu SammourCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0003-1711-6854
Omar SharifInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-7899-2343
Gernot SchabbauerInstitute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-7490-8009
Rüdiger RudolfCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0002-0833-1053
Matthias EckhardtInstitute of Biochemistry and Molecular Biology, University of Bonn, Bonn, Germany.ORCID http://orcid.org/0000-0003-1964-9064
Stefania Alexandra IakabCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany.ORCID http://orcid.org/0000-0002-4156-1942
Laura BindilaClinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center, Mainz University, Mainz, Germany.ORCID http://orcid.org/0000-0001-5538-2008
Carsten HopfCenter for Mass Spectrometry and Optical Spectroscopy (CeMOS), Technische Hochschule Mannheim, Mannheim, Germany. c.hopf@hs-mannheim.de.ORCID http://orcid.org/0000-0003-0802-6451

Funding

Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology) 12FH8I05IABundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology) 13FH8I09IABundesministerium für Bildung, Wissenschaft, Forschung und Technologie (Federal Ministry for Education, Science, Research and Technology) 161L0212F
6 · The paper itself

Abstract

In spatial'omics, highly confident molecular identifications are indispensable for the investigation of complex biology and for spatial biomarker discovery. However, current mass spectrometry imaging (MSI)-based spatial 'omics must compromise between data acquisition speed and biochemical profiling depth. Here, we introduce fast, label-free quantum cascade laser mid-infrared imaging microscopy (QCL-MIR imaging) to guide MSI to high-interest tissue regions as small as kidney glomeruli, cultured multicellular spheroid cores or single motor neurons. Focusing on smaller tissue areas enables extensive spatial lipid identifications by on-tissue tandem-MS employing imaging parallel reaction monitoring-Parallel Accumulation-Serial Fragmentation (iprm-PASEF). QCL-MIR imaging-guided MSI allowed for unequivocal on-tissue elucidation of 157 sulfatides selectively accumulating in kidneys of arylsulfatase A-deficient mice used as ground truth concept and provided chemical rationales for improvements to ion mobility prediction algorithms. Using this workflow, we characterized sclerotic spinal cord lesions in mice with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, and identified upregulation of inflammation-related ceramide-1-phosphate and ceramide phosphatidylethanolamine as markers of white matter lipid remodeling. Taken together, widely applicable and fast QCL-MIR imaging-based guidance of MSI ensures that more time is available for exploration and validation of new biology by default on-tissue tandem-MS analysis.

Indexed as

MicroscopySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleKidneyLasers, SemiconductorMiceMice, Inbred C57BLMotor NeuronsSpinal CordSulfoglycosphingolipidsTandem Mass SpectrometrySulfoglycosphingolipids

Identifiers

PMID40404613
PMCPMC12098849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.